Ipsen – Half year statement – 2022 12 31
This article or press release has no online content. Please download the associated documents for more information.
Attachment
Ipsen – Half year statement – 2022 12 31
This article or press release has no online content. Please download the associated documents for more information.
Attachment
Related Press Releases
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen delivered sales growth and margin expansion in 2020 –...
Ipsen delivers strong sales growth for the first nine months...
Correction: Ipsen announces U.S. FDA submission acceptance of its supplemental...
Ipsen announces U.S. FDA submission acceptance of its supplemental New...
U.S. FDA approves Bylvay® for patients living with cholestatic pruritus...
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen to present new data on clinical outcomes and patient...
Ipsen to present new data on clinical outcomes and patient...
Ipsen to present new data on clinical outcomes and patient...